CSK and atrial fibrillation: Clinical trials and real-world analyses show AF leading to drug discontinuation in 20%–60% of cases where it occurs (Maddocks et al., 2015; Wiczer et al., 2017). Mouse model with cardiomyocyte-specific CSK knockout recapitulates AF phenotype (Xiao et al., 2020).